Impact of Pemafibrate on coronary plaque characteristics in ACS patients
Not Applicable
- Conditions
- ACS patients who underwent OCT guided PCI
- Registration Number
- JPRN-UMIN000034434
- Lead Sponsor
- ara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. SVG or in-stent restenosis lesion 2. Previous history of PCI to the target lesion 3. Vessel with diffuse coronary artery stenosis which is scheduled for PCI 4. Cardiogenic shock 5. Allergy to the study drug (Pemafibrate) 6. Severe lever injury or biliary tract obstruction 7. Moderate to severe renal dysfunction(SCr >2.5mg/dl) 8. Presence of bile stone 9. pregnant or lactating woman 10. Use of Cyclosporine or Rifampicin 11. Insulin requiring diabetes\ 12. Those who are considered as unsuitable candidate by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method